WilliamSFergusonMD

Pediatric Hematology & Oncology • Saint Louis, MO

Physician

Join to view full profile

Dr. Ferguson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Ferguson's full profile

Already have an account?

Office
1465 S Grand Blvd
Saint Louis, MO 63104
Is this information wrong?

Education & Training

Massachusetts General HospitalResidency, Pediatrics, 1982 - 1986
New York University School of MedicineClass of 1982

Certifications & Licensure

MO State Medical License 2004 - 2025
IL State Medical License 2006 - 2023
MA State Medical License 1984 - 2009
RI State Medical License 1996 - 2004
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Start of enrollment: 2004 Sep 04
Completed
Phase 3
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma Start of enrollment: 2004 Apr 01
Active, not recruiting
Phase 3
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma Start of enrollment: 2005 Nov 14
Completed
Phase 3
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors Start of enrollment: 2006 Jun 01
Completed
Phase 2
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor Start of enrollment: 2006 Oct 30
Active, not recruiting
Phase 3
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer Start of enrollment: 2007 May 01
Completed
Phase 3
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor Start of enrollment: 2007 Feb 26
Active, not recruiting
Phase 3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
Active, not recruiting
Phase 3
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin Start of enrollment: 2007 May 01
Completed
Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma Start of enrollment: 2008 Jan 14
Completed
Phase 2
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy Start of enrollment: 2008 Jun 23
Completed
Phase 3
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia Start of enrollment: 2009 Mar 09
Completed
Phase 3
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma Start of enrollment: 2006 Oct 23
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Start of enrollment: 2004 Feb 16
Completed
Study of Blood Samples From Newborns With Down Syndrome Start of enrollment: 2009 Feb 23
Completed
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma Start of enrollment: 2010 Jan 01
Completed
Phase 2
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Active, not recruiting
Phase 3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma Start of enrollment: 2010 Oct 01
Completed
Phase 2
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma Start of enrollment: 2011 Dec 01
Terminated
Phase 1, Phase 2
Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma Start of enrollment: 2011 Dec 01
Terminated
Phase 1, Phase 2
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission Start of enrollment: 2012 Jun 01
Active, not recruiting
Phase 2
A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD) Start of enrollment: 2013 Apr 01
Terminated
Phase 3
Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer Start of enrollment: 2013 Feb 01
Active, not recruiting
Not Applicable
Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis Start of enrollment: 2013 Nov 01
Withdrawn
Phase 2
Molecular-Guided Therapy for Childhood Cancer Start of enrollment: 2014 Jul 08
Completed
Not Applicable
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy Start of enrollment: 2015 Sep 01
Recruiting
Phase 2
Trial of Tolcapone With Oxaliplatin for Neuroblastoma Start of enrollment: 2015 Dec 01
Terminated
Phase 1
Neuroblastoma Maintenance Therapy Trial Start of enrollment: 2016 Feb 01
Recruiting
Phase 2
Beat Childhood Cancer Specimen Banking and Data Registry Start of enrollment: 2021 Feb 02
Recruiting
Join now to see all

Publications & Presentations

PubMed

3 citations
A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma.
Jacqueline M Kraveka, Elizabeth C Lewis, Genevieve Bergendahl, William Ferguson, Javier Oesterheld, Elizabeth Kim, Abhinav B Nagulapally, Karl J Dykema, Valerie I Brow...> ;Cancer Reports. 2022 Nov 1
5 citations
A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma.
Giselle Saulnier-Sholler, Dan G Duda, Genevieve Bergendahl, David Ebb, Matija Snuderl, Theodore W Laetsch, Jennifer Michlitsch, Derek Hanson, Michael S Isakoff, Kevin ...> ;Clinical Cancer Research. 2022 Sep 15
8 citations
Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion
Sara A. Byron, William P.D. Hendricks, Abhinav Nagulapally, Jacqueline M. Kraveka, William S. Ferguson, Valerie I. Brown, Don E Eslin, Deanna Mitchell, Albert Corneliu...> ;Cancer Research. 2021 Oct 5
Analysis of outcomes of single-unit cord blood transplantation with umbilical cord blood units processed with two different red blood cell sedimentation reagents.
Aleksandar Babic, Paula Buchanan, Ammara Gill, Jenni Bloomquist, Donna Regan, Deepika Bhatla, William S. Ferguson> ;Transfusion. 2021 May 20
30 citations
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma
Elizabeth C. Lewis, Jacqueline M. Kraveka, William S. Ferguson, Don Eslin, Valerie I. Brown, Genevieve Bergendahl, William Roberts, Randal K. Wada, Javier Oesterheld, ...> ;International Journal of Cancer. 2020 Dec 1
The fault…is not in our stars, but in ourselves.
William S. Ferguson> ;The Journal of Pediatrics. 2020 Jan 1
2 citations
Outcomes of processing of bone marrow harvests for hematopoietic stem cell transplantation in pediatric patients utilizing a novel red blood cell sedimentation kit
Salem M. Akel, Christianna Murray, William S. Ferguson, Aleksandar Babic> ;Transfusion. 2019 Jul 1
Fever and Altered Mental Status in an Adolescent Male With Burkitt Lymphoma.
Elizabeth A. Bergamini, Shubhangi Peche, William S. Ferguson, Anthony J. Scalzo, Nandini Calamur> ;Clinical Pediatrics. 2019 Apr 21
6 citations
Extrahepatic Nonreticuloendothelial Siderosis Is Not Specific to Gestational Alloimmune Liver Disease.
Hao Wu, William S. Ferguson, Eumenia Costa da Cunha Castro, Debra L. Kearney, Milton J. Finegold, Kalyani R. Patel> ;Pediatric and Developmental Pathology. 2019 Feb 5
1 citations
School performance in childhood leukemia survivors.
William S. Ferguson> ;The Journal of Pediatrics. 2019 Feb 1
82 citations
Unveiling the Role of the Most Impactful Cardiovascular Risk Locus through Haplotype Editing.
Valentina Lo Sardo, Pavel Chubukov, William S. Ferguson, Aditya Kumar, Evan L. Teng, Michael A. Duran, Lei Zhang, Gregory J. Cost, Adam J. Engler, Fyodor D. Urnov, Eri...> ;Cell. 2018 Dec 13
58 citations
Maintenance DFMO Increases Survival in High Risk Neuroblastoma
Giselle Saulnier Sholler, William S. Ferguson, Genevieve Bergendahl, Jeffrey P. Bond, Kathleen A. Neville, Don Eslin, Valerie I. Brown, William Roberts, Randal K. Wada...> ;Scientific Reports. 2018 Sep 27
1 citations
The incidental detection of alpha thalassemia.
William S. Ferguson> ;The Journal of Pediatrics. 2018 Apr 1
50 Years Ago in The Journal of Pediatrics: A Study of "Total Therapy" of Acute Lymphocytic Leukemia in Children.
William S. Ferguson> ;The Journal of Pediatrics. 2018 Mar 1
4 citations
Additivity of nebivolol/valsartan single-pill combinations versus other single-pill combinations for hypertension.
Jack Ishak, Michael Rael, Henry Punzi, Alan H. Gradman, Lynn M. Anderson, Mehul Patel, Sanjida Ali, William S. Ferguson, Joel M. Neutel> ;Journal of Clinical Hypertension. 2018 Jan 1
Combination immune-based therapy for chronic ITP.
William S. Ferguson> ;The Journal of Pediatrics. 2017 Dec 1
2 citations
Iron deficiency in adolescence.
William S. Ferguson> ;The Journal of Pediatrics. 2017 Aug 1
3 citations
Pediatric Mesenchymal Hamartomas of the Liver can Show Both Foregut and Hindgut Phenotype.
Hao Wu, William S. Ferguson, Eumenia Costa da Cunha Castro, Milton J. Finegold, Kalyani R. Patel> ;Pediatric and Developmental Pathology. 2017 May 4
Red cell antibody formation in the newborn.
William S. Ferguson> ;The Journal of Pediatrics. 2017 Feb 1
127 citations
Influence of donor age on induced pluripotent stem cells
Valentina Lo Sardo, William S. Ferguson, Galina Erikson, Eric J. Topol, Kristin K. Baldwin, Ali Torkamani> ;Nature Biotechnology. 2017 Jan 1
Iron deficiency: a new alternative when oral iron fails.
William S. Ferguson> ;The Journal of Pediatrics. 2017 Jan 1
14 citations
Association of Posttraumatic Growth and Illness-Related Burden With Psychosocial Factors of Patient, Family, and Provider in Pediatric Cancer Survivors
J. Zachary Wilson, Donna Marin, Katherine Maxwell, Joseph Cumming, Ryan Berger, Shermini Saini, William S. Ferguson, John T. Chibnall> ;Journal of Traumatic Stress. 2016 Oct 1
1 citations
Iron deficiency anemia: like mother, like child
William S. Ferguson> ;The Journal of Pediatrics. 2016 Aug 1
Additivity of Nebivolol/Valsartan Single-Pill Combination Versus Other Single-Pill Combinations for Hypertension.
J. Ishak, M. Rael, Henry Punzi, Alan H. Gradman, Mehul Patel, S. Ali, William S. Ferguson, Joel M. Neutel> ;Journal of the American Society of Hypertension. 2016 Jul 1
Kids clot, too—just not like adults
William S. Ferguson> ;The Journal of Pediatrics. 2016 May 1
Join now to see all